A detailed history of Cibc Asset Management Inc transactions in Organon & Co. stock. As of the latest transaction made, Cibc Asset Management Inc holds 24,339 shares of OGN stock, worth $362,407. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,339
Previous 24,682 1.39%
Holding current value
$362,407
Previous $510,000 8.82%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$18.65 - $23.03 $6,396 - $7,899
-343 Reduced 1.39%
24,339 $465,000
Q2 2024

Aug 01, 2024

SELL
$17.45 - $21.96 $36,592 - $46,050
-2,097 Reduced 7.83%
24,682 $510,000
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $3,913 - $5,339
-284 Reduced 1.05%
26,779 $503,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $87,928 - $139,079
-8,030 Reduced 22.88%
27,063 $390,000
Q3 2023

Oct 30, 2023

SELL
$16.59 - $23.77 $8,212 - $11,766
-495 Reduced 1.39%
35,093 $609,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $7,206 - $9,211
-374 Reduced 1.04%
35,588 $740,000
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $21,805 - $32,657
1,018 Added 2.91%
35,962 $845,000
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $103,939 - $127,571
-4,459 Reduced 11.32%
34,944 $976,000
Q3 2022

Nov 03, 2022

BUY
$23.4 - $34.25 $68,585 - $100,386
2,931 Added 8.04%
39,403 $922,000
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $76,363 - $93,826
2,412 Added 7.08%
36,472 $1.23 Million
Q1 2022

May 06, 2022

BUY
$30.45 - $39.36 $117,689 - $152,126
3,865 Added 12.8%
34,060 $1.19 Million
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $5,533 - $7,166
-193 Reduced 0.64%
30,195 $919,000
Q3 2021

Nov 09, 2021

SELL
$28.63 - $35.64 $68,597 - $85,393
-2,396 Reduced 7.31%
30,388 $996,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $932,704 - $1.25 Million
32,784 New
32,784 $992,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.